Cross-linking of Thy-1 glycoproteins or high-affinity IgE receptors induces mast cell activation via different mechanisms

. 1993 Sep ; 80 (1) : 103-9.

Jazyk angličtina Země Velká Británie, Anglie Médium print

Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, U.S. Gov't, P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/pmid07902332

Rat peritoneal and pleural mast cells and rat basophilic leukemia cells, RBL-2H3, have been previously shown to be activated by Thy-1-specific monoclonal antibodies (mAb). In the present study we investigated the mechanism of Thy-1-mediated activation and compared it with activation induced by cross-linking of the high-affinity IgE receptor. Binding of an IgG Thy-1 x 1-specific mAb, MRCOX7 (OX7), to RBL-2H3 cells and mast cells, and activation of RBL-2H3 by the OX7 were abrogated by pretreatment of the cells with phosphatidyl inositol-specific phospholipase C (PI-PLC). The F(ab')2 fragment of OX7, in contrast to the Fab' fragment, induced cell activation as well as intact OX7 mAb. Cells sensitized with IgE exhibited an increased responsiveness to anti-Thy-1 antibodies suggesting formation of functional complexes of IgE receptor/IgE/Thy-1/anti-Thy-1. Pretreatment of RBL-2H3 cells with cholera toxin potentiated activation induced by IgE+antigen (Ag) and IgE+OX7, but had no effect on activation induced by OX7 antibody alone. Similarly, dexamethasone had no effect on OX7-induced activation but inhibited IgE+Ag- and IgE+OX7-induced activation. Analysis of phosphotyrosine-containing proteins in RBL-2H3 cell lysates revealed that IgE+Ag and IgE+OX7 induced a marked increase in tyrosine phosphorylation of several proteins that were not tyrosine phosphorylated in cells exposed to OX7 mAb alone. Similar results were obtained when RBL-2H3-derived cells, expressing transfected mouse Thy-1.2, were activated with Thy-1.2-specific IgM antibody. The combined data suggest that Thy-1-specific antibodies activate cells by a mechanism that is different from activation induced by cross-linking of high-affinity IgE receptor.

Zobrazit více v PubMed

Nature. 1970 Aug 15;227(5259):680-5 PubMed

Int Immunol. 1991 Apr;3(4):333-42 PubMed

Anal Biochem. 1976 May 7;72:248-54 PubMed

Exp Cell Res. 1977 Feb;104(2):255-62 PubMed

J Immunol. 1977 Nov;119(5):1589-96 PubMed

J Immunol. 1978 Aug;121(2):549-58 PubMed

Eur J Immunol. 1979 Mar;9(3):219-4 PubMed

Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PubMed

Eur J Immunol. 1979 Nov;9(11):875-86 PubMed

Biochem J. 1980 Apr 1;187(1):1-20 PubMed

J Immunogenet. 1980 Dec;7(6):455-74 PubMed

Eur J Immunol. 1981 Apr;11(4):317-23 PubMed

Eur J Immunol. 1981 Jun;11(6):527-9 PubMed

Eur J Immunol. 1984 Sep;14(9):799-807 PubMed

J Immunol. 1987 Mar 15;138(6):1914-8 PubMed

Prog Allergy. 1988;42:123-84 PubMed

Prog Allergy. 1988;42:185-245 PubMed

Eur J Immunol. 1989 Sep;19(9):1715-20 PubMed

J Biol Chem. 1990 Jan 15;265(2):745-53 PubMed

J Immunol. 1990 May 1;144(9):3449-57 PubMed

Proc Natl Acad Sci U S A. 1990 Jul;87(14):5327-30 PubMed

J Biol Chem. 1991 Nov 25;266(33):22613-20 PubMed

J Biol Chem. 1992 Mar 15;267(8):5434-41 PubMed

Immunol Today. 1992 Jun;13(6):195-7 PubMed

Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3611-5 PubMed

Immunol Today. 1991 Jan;12(1):35-41 PubMed

Biochem Biophys Res Commun. 1991 May 31;177(1):192-201 PubMed

Eur J Immunol. 1991 Jul;21(7):1583-90 PubMed

Clin Exp Allergy. 1991 May;21(3):269-79 PubMed

Cell Immunol. 1975 Dec;20(2):133-55 PubMed

Najít záznam

Citační ukazatele

Možnosti archivace